Cargando…
Conformational state interactions provide clues to the pharmacochaperone potential of serotonin transporter partial substrates
Point mutations in SLC6 transporters cause misfolding, which can be remedied by pharmacochaperones. The serotonin transporter (SERT/SLC6A4) has a rich pharmacology including inhibitors, releasers (amphetamines, which promote the exchange mode), and more recently, discovered partial substrates. We hy...
Autores principales: | Bhat, Shreyas, Hasenhuetl, Peter S., Kasture, Ameya, El-Kasaby, Ali, Baumann, Michael H., Blough, Bruce E., Sucic, Sonja, Sandtner, Walter, Freissmuth, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633137/ https://www.ncbi.nlm.nih.gov/pubmed/28842491 http://dx.doi.org/10.1074/jbc.M117.794081 |
Ejemplares similares
-
Pharmacochaperoning in a Drosophila model system rescues human dopamine transporter variants associated with infantile/juvenile parkinsonism
por: Asjad, H. M. Mazhar, et al.
Publicado: (2017) -
The N Terminus Specifies the Switch between Transport Modes of the Human Serotonin Transporter
por: Kern, Carina, et al.
Publicado: (2017) -
Switching the Clientele: A LYSINE RESIDING IN THE C TERMINUS OF THE SEROTONIN TRANSPORTER SPECIFIES ITS PREFERENCE FOR THE COAT PROTEIN COMPLEX II COMPONENT SEC24C
por: Sucic, Sonja, et al.
Publicado: (2013) -
A mechanism of uncompetitive inhibition of the serotonin transporter
por: Bhat, Shreyas, et al.
Publicado: (2023) -
Dual Action of Zn(2+) on the Transport Cycle of the Dopamine Transporter
por: Li, Yang, et al.
Publicado: (2015)